| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |